Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Metformin is the first-line oral medication recommended for glycemic control in patients with type 2 diabetes. We reviewed the literature to quantify the effect of metformin treatment on glycated hemoglobin (HbA(1c)) levels in all types of diabetes and examine the impact of differing doses on glycemic control.

More information
Type

Journal article

Journal

Diabetes Care

Publication Date

02/2012

Volume

35

Pages

446 - 454

Keywords

Blood Glucose, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Metformin